Join in on this enthusiastic and insightful conversation between Nathan Brendish, associated with the University of Southampton in the United Kingdom, and Irene Gonzalez and Florian Krammer from the Icahn School of Medicine at Mount Sinai in the United States of America. Explore the joys and sorrows of embarking on a scientific career in this episode as we delve into the nomadic life of scientists as they explore the world in search of new and existing data in the field of respiratory viruses.

Do not miss the opportunity to listen to this enthusiastic and insightful conversation between Debby van Riel, Associate Professor, Department of Viroscience, Erasmus MC, The Netherlands, Carolien van de Sandt, Senior Research Fellow, Department of Microbiology and Immunology at the Peter Doherty Institute, Australia, and Jenna Guthmiller Assistant Professor at the Department of Immunology and Microbiology from University of Colorado Anschutz Medical Campus, US, examine the joys and sprrows of embarking on a scientific career.

How does the real-life experience of working as a scientist compare to your initial

Expectations? What are the typical challenges encountered by early career scientists? What advice would you give to someone considering a career in science? Looking ahead, what are the big questions that you want to address? What advice would you give to someone considering a career in science?

In this comprehensive exploration and conversation among distinguished experts in the field of childhood immunisation we listen to Paula Tähtinen, Clinical Lecturer, Paediatrics and Adolescent Medicine / Adjunct Professor, University of Turku and ESWI Board Member, Hanna Nohynek, Chief Medical Officer, Team Leader of Vaccine Programme Development at the National Institute for Health and Welfare, Finland, together with Sir Andrew Pollard, Professor of Paediatric Infection & Immunity at University of Oxford and the Director of the Oxford Vaccine Group succinctly cover the context of vaccinating against flu, RSV and COVID-19.

Is there a difference between recommending flu, RSV and COVID-19 vaccinations in children? What is meant by preventing secondary diseases and other societal wider benefits? What factors are considered before a country introduces a new vaccine in its national vaccination programme? How long does it usually take before a vaccine is rolled-out? And who are the happy wheezers?

Flu is the forgotten killer. What new vistas of vaccinology opened up after the COVID-19 pandemic? In what ways can flu treatments change as a consequence of lessons learned? 

Listen to this excellent panel of experts, Peter Openshaw,  Respiratory physician and Mucosal Immunologist, Professor of Experimental Medicine, Imperial College, London and ESWI Board Member, Anthony Gordon, Chair in Anaesthesia and Critical Care, NIHR Research Professor and Senior Investigator, Imperial College, London, and Susanne Herold, Professor of Medicine, Infectious Diseases and Pulmonary Research, University Hospital Giessen und Marburg, eloquently converse about what the COVID-19 pandemic taught us and how it can help to improve how we deal with flu; And learn what the architects in the Victorian age got right with regards to prevention!

How has the world of travel medicine evolved? What multiple roles do vaccinations have? What impact did the COVID-19 pandemic have on travel behaviour? Why is it so important to keep up to date on the current epidemiological situation? 

Delve into the fascinating world of travel medicine, listening to George Kassianos, GP, ESWI Board Member and President of the British Global and Travel Health Association, Dipti Patel, Specialist in occupational medicine and travel medicine physician and Director at the National Travel Health Network and Centre and Robert Steffen, Emeritus Professor at the Epidemiology, Biostatistics and Prevention Institute, University of Zurich, also known as the father of travel medicine. We learn which group of travellers are - surprisingly - of most concern for health care specialists, and what some of the geographical hotspots are. We will also get a snapshot of the recommended updated Covid-19 vaccine, and much more. 

What do we know about long-Covid? In this captivating episode we listen to the personal and powerful account of how the lingering effects of Sars-CoV-2 has wreaked havoc in an otherwise healthy person “The virus is playing ping-pong with my body”, Norah Casey broadcaster and entrepreneur says when describing all the symptoms in her medically impressive case. Marco Goeijenbier, intensivist and ESWI Board Member together with Merel Hellemons, pulmonologist and researcher with a special interest in long-Covid give an astute description of post-infection syndromes, differences among respiratory virus infections and what is known to date about long-Covid.

Why should older adults be particularly careful of acute respiratory viruses? What are risk factors for adverse outcomes? Why is RSV typically under-diagnosed in adults compared with flu and what are some of the long-term impacts? Are older adults always more at risk in a pandemic?  What do we mean by ageism and what needs to be done to counter it. 

Listen to this powerful panel of experts, literally spanning the globe, featuring Stefania Maggi ESWI Board Member, Geriatrician and Epidemiologist based in Italy, Kirsty Short, virologist from the University of Queensland Australia, and Jane Barratt, Secretary General, International Federation on Ageing in Canada, shedding light on these questions and more.

The shocking numbers of babies and children who die, or who are in need of care, coupled with the rising number of undiagnosed older adults puts a significant burden from RSV on health systems. The risk of severe RSV illness can be mitigated and thus there is an urgency for increasing awareness of the impact of RSV.

Listen to Colin Russell, ESWI Board Member and Professor of Applied Evolutionary Biology, Elizabeth Kuiper, Head of the Social Europe and Well-being programme at the European Policy Centre and George Valiotis, Executive Director of the European Health Management Association expertly untangle the economic and societal impact of acute respiratory viruses with a focus on RSV. They cover everything from air pollution, deep-rooted health inequalities, need for data and surveillance, immunisation programmes, health management to the newly established EU Health Union